Literature DB >> 21791550

Common variants at VRK2 and TCF4 conferring risk of schizophrenia.

Stacy Steinberg1, Simone de Jong, Ole A Andreassen, Thomas Werge, Anders D Børglum, Ole Mors, Preben B Mortensen, Omar Gustafsson, Javier Costas, Olli P H Pietiläinen, Ditte Demontis, Sergi Papiol, Johanna Huttenlocher, Manuel Mattheisen, René Breuer, Evangelos Vassos, Ina Giegling, Gillian Fraser, Nicholas Walker, Annamari Tuulio-Henriksson, Jaana Suvisaari, Jouko Lönnqvist, Tiina Paunio, Ingrid Agartz, Ingrid Melle, Srdjan Djurovic, Eric Strengman, Gesche Jürgens, Birte Glenthøj, Lars Terenius, David M Hougaard, Torben Ørntoft, Carsten Wiuf, Michael Didriksen, Mads V Hollegaard, Merete Nordentoft, Ruud van Winkel, Gunter Kenis, Lilia Abramova, Vasily Kaleda, Manuel Arrojo, Julio Sanjuán, Celso Arango, Swetlana Sperling, Moritz Rossner, Michele Ribolsi, Valentina Magni, Alberto Siracusano, Claus Christiansen, Lambertus A Kiemeney, Jan Veldink, Leonard van den Berg, Andres Ingason, Pierandrea Muglia, Robin Murray, Markus M Nöthen, Engilbert Sigurdsson, Hannes Petursson, Unnur Thorsteinsdottir, Augustine Kong, I Alex Rubino, Marc De Hert, János M Réthelyi, István Bitter, Erik G Jönsson, Vera Golimbet, Angel Carracedo, Hannelore Ehrenreich, Nick Craddock, Michael J Owen, Michael C O'Donovan, Mirella Ruggeri, Sarah Tosato, Leena Peltonen, Roel A Ophoff, David A Collier, David St Clair, Marcella Rietschel, Sven Cichon, Hreinn Stefansson, Dan Rujescu, Kari Stefansson.   

Abstract

Common sequence variants have recently joined rare structural polymorphisms as genetic factors with strong evidence for association with schizophrenia. Here we extend our previous genome-wide association study and meta-analysis (totalling 7 946 cases and 19 036 controls) by examining an expanded set of variants using an enlarged follow-up sample (up to 10 260 cases and 23 500 controls). In addition to previously reported alleles in the major histocompatibility complex region, near neurogranin (NRGN) and in an intron of transcription factor 4 (TCF4), we find two novel variants showing genome-wide significant association: rs2312147[C], upstream of vaccinia-related kinase 2 (VRK2) [odds ratio (OR) = 1.09, P = 1.9 × 10(-9)] and rs4309482[A], between coiled-coiled domain containing 68 (CCDC68) and TCF4, about 400 kb from the previously described risk allele, but not accounted for by its association (OR = 1.09, P = 7.8 × 10(-9)).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791550      PMCID: PMC3298077          DOI: 10.1093/hmg/ddr325

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

Review 1.  Initial impact of the sequencing of the human genome.

Authors:  Eric S Lander
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

2.  Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase.

Authors:  J Nezu; A Oku; M H Jones; M Shimane
Journal:  Genomics       Date:  1997-10-15       Impact factor: 5.736

3.  JIP1 regulates neuronal apoptosis in response to stress.

Authors:  Zhaohui Dong; Li Zhou; Keith Del Villar; Mahin Ghanevati; Vartan Tashjian; Carol A Miller
Journal:  Brain Res Mol Brain Res       Date:  2005-04-04

Review 4.  Ubiquitylation and the Fanconi anemia pathway.

Authors:  Elizabeth Garner; Agata Smogorzewska
Journal:  FEBS Lett       Date:  2011-05-19       Impact factor: 4.124

5.  Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival.

Authors:  Long-Yuan Li; Mei-Ying Liu; Hsiu-Ming Shih; Ching-Hwa Tsai; Jen-Yang Chen
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

6.  E2-2 protein and Fuchs's corneal dystrophy.

Authors:  Keith H Baratz; Nirubol Tosakulwong; Euijung Ryu; William L Brown; Kari Branham; Wei Chen; Khoa D Tran; Katharina E Schmid-Kubista; John R Heckenlively; Anand Swaroop; Goncalo Abecasis; Kent R Bailey; Albert O Edwards
Journal:  N Engl J Med       Date:  2010-08-25       Impact factor: 91.245

7.  The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.

Authors:  Solveig Gretarsdottir; Gudmar Thorleifsson; Sigridur Th Reynisdottir; Andrei Manolescu; Sif Jonsdottir; Thorbjörg Jonsdottir; Thorunn Gudmundsdottir; Sigrun M Bjarnadottir; Olafur B Einarsson; Herdis M Gudjonsdottir; Malcolm Hawkins; Gudmundur Gudmundsson; Hrefna Gudmundsdottir; Hjalti Andrason; Asta S Gudmundsdottir; Matthildur Sigurdardottir; Thomas T Chou; Joseph Nahmias; Shyamali Goss; Sigurlaug Sveinbjörnsdottir; Einar M Valdimarsson; Finnbogi Jakobsson; Uggi Agnarsson; Vilmundur Gudnason; Gudmundur Thorgeirsson; Jurgen Fingerle; Mark Gurney; Daniel Gudbjartsson; Michael L Frigge; Augustine Kong; Kari Stefansson; Jeffrey R Gulcher
Journal:  Nat Genet       Date:  2003-09-21       Impact factor: 38.330

8.  Identification of blood biomarkers for psychosis using convergent functional genomics.

Authors:  S M Kurian; H Le-Niculescu; S D Patel; D Bertram; J Davis; C Dike; N Yehyawi; P Lysaker; J Dustin; M Caligiuri; J Lohr; D K Lahiri; J I Nurnberger; S V Faraone; M A Geyer; M T Tsuang; N J Schork; D R Salomon; A B Niculescu
Journal:  Mol Psychiatry       Date:  2009-11-24       Impact factor: 15.992

9.  The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus.

Authors:  R Jeremy Nichols; Matthew S Wiebe; Paula Traktman
Journal:  Mol Biol Cell       Date:  2006-02-22       Impact factor: 4.138

10.  The JIP1 scaffold protein regulates axonal development in cortical neurons.

Authors:  Federico Dajas-Bailador; Emma V Jones; Alan J Whitmarsh
Journal:  Curr Biol       Date:  2008-02-12       Impact factor: 10.834

View more
  87 in total

Review 1.  Genetic architectures of psychiatric disorders: the emerging picture and its implications.

Authors:  Patrick F Sullivan; Mark J Daly; Michael O'Donovan
Journal:  Nat Rev Genet       Date:  2012-07-10       Impact factor: 53.242

Review 2.  Genome-wide association studies of schizophrenia: does bigger lead to better results?

Authors:  Sarah E Bergen; Tracey L Petryshen
Journal:  Curr Opin Psychiatry       Date:  2012-03       Impact factor: 4.741

3.  Type I bHLH Proteins Daughterless and Tcf4 Restrict Neurite Branching and Synapse Formation by Repressing Neurexin in Postmitotic Neurons.

Authors:  Mitchell D'Rozario; Ting Zhang; Edward A Waddell; Yonggang Zhang; Cem Sahin; Michal Sharoni; Tina Hu; Mohammad Nayal; Kaveesh Kutty; Faith Liebl; Wenhui Hu; Daniel R Marenda
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

4.  Common polygenic variation and risk for childhood-onset schizophrenia.

Authors:  K Ahn; S S An; Y Y Shugart; J L Rapoport
Journal:  Mol Psychiatry       Date:  2014-12-16       Impact factor: 15.992

5.  Common variants in the MKL1 gene confer risk of schizophrenia.

Authors:  Xiong-Jian Luo; Liang Huang; Edwin J van den Oord; Karolina A Aberg; Lin Gan; Zhongming Zhao; Yong-Gang Yao
Journal:  Schizophr Bull       Date:  2014-11-07       Impact factor: 9.306

6.  Associations between TCF4 gene polymorphism and cognitive functions in schizophrenia patients and healthy controls.

Authors:  Xianghua Zhu; Huang Gu; Zhen Liu; Zhansheng Xu; Xiongying Chen; Xiaochen Sun; Jinguo Zhai; Qiumei Zhang; Min Chen; Keqin Wang; Xiaoxiang Deng; Feng Ji; Chuanxin Liu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2012-11-09       Impact factor: 7.853

7.  Transcription factor 4 gene rs9960767 polymorphism in bipolar disorder.

Authors:  Mavi Deniz Ozel; Mehmet Emin Onder; Ali Sazci
Journal:  Biomed Rep       Date:  2016-08-23

8.  Building a schizophrenia genetic network: transcription factor 4 regulates genes involved in neuronal development and schizophrenia risk.

Authors:  Hanzhang Xia; Fay M Jahr; Nak-Kyeong Kim; Linying Xie; Andrey A Shabalin; Julien Bryois; Douglas H Sweet; Mohamad M Kronfol; Preetha Palasuberniam; MaryPeace McRae; Brien P Riley; Patrick F Sullivan; Edwin J van den Oord; Joseph L McClay
Journal:  Hum Mol Genet       Date:  2018-09-15       Impact factor: 6.150

9.  The Anorexia Nervosa Genetics Initiative (ANGI): Overview and methods.

Authors:  Laura M Thornton; Melissa A Munn-Chernoff; Jessica H Baker; Anders Juréus; Richard Parker; Anjali K Henders; Janne T Larsen; Liselotte Petersen; Hunna J Watson; Zeynep Yilmaz; Katherine M Kirk; Scott Gordon; Virpi M Leppä; Felicity C Martin; David C Whiteman; Catherine M Olsen; Thomas M Werge; Nancy L Pedersen; Walter Kaye; Andrew W Bergen; Katherine A Halmi; Michael Strober; Allan S Kaplan; D Blake Woodside; James Mitchell; Craig L Johnson; Harry Brandt; Steven Crawford; L John Horwood; Joseph M Boden; John F Pearson; Laramie E Duncan; Jakob Grove; Manuel Mattheisen; Jennifer Jordan; Martin A Kennedy; Andreas Birgegård; Paul Lichtenstein; Claes Norring; Tracey D Wade; Grant W Montgomery; Nicholas G Martin; Mikael Landén; Preben Bo Mortensen; Patrick F Sullivan; Cynthia M Bulik
Journal:  Contemp Clin Trials       Date:  2018-10-01       Impact factor: 2.226

10.  Vaccinia-related kinase 2 mediates accumulation of polyglutamine aggregates via negative regulation of the chaperonin TRiC.

Authors:  Sangjune Kim; Do-Young Park; Dohyun Lee; Wanil Kim; Young-Hun Jeong; Juhyun Lee; Sung-Kee Chung; Hyunjung Ha; Bo-Hwa Choi; Kyong-Tai Kim
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.